12:00 AM
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

99mTc-MIP-1404: Phase II started

Molecular Insight began an open-label, international Phase II trial to evaluate a single IV dose of 99mTc-MIP-1404 followed by SPECT/CT scans 3-6 hours after injection in up to 120...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >